5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
BUY | NEUTRAL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 9.02▲ | 9.00▲ | 9.02▲ | 9.38▼ | 8.69▲ |
MA10 | 9.00▲ | 9.03▲ | 9.07▼ | 9.35▼ | 9.13▼ |
MA20 | 8.98▲ | 9.09▼ | 9.20▼ | 8.60▲ | 11.20▼ |
MA50 | 9.01▲ | 9.32▼ | 9.48▼ | 9.06▼ | 17.05▼ |
MA100 | 9.07▼ | 9.44▼ | 8.91▲ | 11.94▼ | 19.03▼ |
MA200 | 9.21▼ | 8.82▲ | 8.52▲ | 16.95▼ | 24.48▼ |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.012▲ | 0.005▲ | -0.014▼ | 0.144▲ | 0.134▲ |
RSI | 57.112▲ | 43.421▼ | 39.769▼ | 50.184▲ | 35.190▼ |
STOCH | 84.133▲ | 29.714 | 26.772 | 62.459 | 25.873 |
WILL %R | -13.043▲ | -68.293 | -73.196 | -40.351 | -71.077 |
CCI | 139.108▲ | -28.139 | -70.026 | 16.489 | -28.635 |
Wednesday, May 07, 2025 02:30 PM
Xencor (XNCR) came out with a quarterly loss of $0.66 per share versus the Zacks Consensus Estimate of a loss of $0.63. This compares to loss of $1.11 per share a year ago. These figures are ...
|
Tuesday, May 06, 2025 05:00 PM
PASADENA, Calif., May 07, 2025--Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases ...
|
Tuesday, May 06, 2025 05:00 PM
Xencor (NASDAQ:XNCR – Get Free Report) is anticipated to release its Q1 2025 earnings data before the market opens on Thursday, May 8th.Analysts expect the company to announce earnings of ($0.60 ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/06/25 | 9.08 | 9.32 | 8.91 | 9.04 | 307,246 |
13/06/25 | 9.17 | 9.455 | 9.00 | 9.19 | 421,600 |
12/06/25 | 9.29 | 9.60 | 9.15 | 9.43 | 451,900 |
11/06/25 | 9.82 | 9.98 | 9.48 | 9.52 | 482,500 |
10/06/25 | 9.64 | 10.19 | 9.57 | 9.73 | 414,533 |
09/06/25 | 9.96 | 9.97 | 9.50 | 9.55 | 800,618 |
06/06/25 | 9.24 | 9.89 | 9.23 | 9.65 | 525,200 |
05/06/25 | 9.04 | 9.13 | 8.775 | 9.12 | 553,960 |
04/06/25 | 9.16 | 9.60 | 9.08 | 9.10 | 796,400 |
03/06/25 | 8.64 | 9.33 | 8.43 | 9.14 | 1,388,322 |
|
|
||||
|
|
||||
|
|